GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » FCF Margin %

Haleon (Haleon) FCF Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Haleon's Free Cash Flow for the three months ended in Mar. 2024 was $0 Mil. Haleon's Revenue for the three months ended in Mar. 2024 was $3,709 Mil. Therefore, Haleon's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Haleon's current FCF Yield % is 5.93%.

The historical rank and industry rank for Haleon's FCF Margin % or its related term are showing as below:

HLN' s FCF Margin % Range Over the Past 10 Years
Min: 6.4   Med: 11.08   Max: 15.98
Current: 15.78


During the past 5 years, the highest FCF Margin % of Haleon was 15.98%. The lowest was 6.40%. And the median was 11.08%.

HLN's FCF Margin % is ranked better than
85.69% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.42 vs HLN: 15.78


Haleon FCF Margin % Historical Data

The historical data trend for Haleon's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon FCF Margin % Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
6.40 11.01 11.08 15.98 15.61

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Haleon's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleon's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Haleon's FCF Margin % falls into.



Haleon FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Haleon's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=2232.912/14306.329
=15.61 %

Haleon's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=0/3709.022
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haleon FCF Margin % Related Terms

Thank you for viewing the detailed overview of Haleon's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon (Haleon) Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.